By Deron Hamel Epilepsy Ontario is urging people taking 250-mg soft-gel capsules of the anti-seizure medication Zarontin (ethosuximide) to closely scrutinize their capsules to ensure they are not defective, following a warning issued by Erfa Canada 2012 Inc. and Health Canada. Erfa Canada 2012 Inc., the company that manufactures Zarontin, and Health Canada have received…
By Deron Hamel Epilepsy Ontario announced today that it has entered a partnership with EpLink to fund a study to research the link between brain trauma and the development of epilepsy. There is a body of evidence that shows people who suffer brain trauma are at increased risk of developing epilepsy. What is not known…
By Deron Hamel Epilepsy Ontario is working on a project to create an information package epilepsy support agencies across the province can use to educate police services and first responders on how to identify people who are having a non-convulsive seizure. The provincial agency is adapting a project created by Epilepsy Toronto to help build…
By Deron Hamel EpLink, the epilepsy research program of the Ontario Brain Institute (OBI), is hoping to garner as much feedback as possible through a survey to help the organization prioritize research. The survey is aimed at people living with epilepsy, their families and those working at epilepsy support agencies. EpLink’s No. 1 priority is…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
